Clinical and immunologic aspects of egg donation pregnancies: A systematic review

Human Reproduction Update

Volumn 16, Issue 6, 2010, Pages 704-712

  van der Hoorn, M L P ^a   Lashley, E E L O ^a   Bianchi, D W ^b   Claas, F H J ^a   Schonkeren, C M C ^a   Scherjon, S A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Egg donation; Oocyte donation; Pregnancy complications; Pregnancy outcome; Reproductive immunology

Indexed keywords

ANTIGENICITY; ARTICLE; BLOOD TRANSFUSION; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; EGG DONATION; FEMALE; FERTILIZATION IN VITRO; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; INFERTILITY THERAPY; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MEDICAL LITERATURE; MEDLINE; NEWBORN DISEASE; OBSTETRIC HEMORRHAGE; ORGAN TRANSPLANTATION; PLACENTA DISORDER; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EMBRYO TRANSFER; EMBRYO, MAMMALIAN; FEMALE; HUMANS; OOCYTE DONATION; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 78649354212     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmq017     Document Type: Article

References (79)

1. Abdalla HI, Wren ME, Thomas A, Korea L. Age of the uterus does not affect pregnancy or implantation rates; a study of egg donation in women of different ages sharing oocytes from the same donor. Hum Reprod 1997;12:827-829.
2. Abdalla HI, Billett A, Kan AK, Baig S, Wren M, Korea L, Studd JW. Obstetric outcome in 232 ovum donation pregnancies. Br J Obstet Gynaecol 1998;105:332-337.
3. Allen VM, Wilson RD, Cheung A. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can 2006;28:220-250.
4. Bayle F, Masson D, Zaoui P, Vialtel P, Janbon B, Bensa JC, Cordonnier DJ. Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. Transplantation 1995; 59:719-723.
5. Bellver J, Rossal LP, Bosch E, Zuniga A, Corona JT, Melendez F, Gomez E, Simon C, Remohi J, Pellicer A. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 2003;79:1136-1140.
6. Blanchette H. Obstetric performance of patients after oocyte donation. Am J Obstet Gynecol 1993;168:1803-1807.
7. Borini A, Bafaro G, Violini F, Bianchi L, Casadio V, Flamigni C. Pregnancies in postmenopausal women over 50 years old in an oocyte donation program. Fertil Steril 1995;63:258-261.
8. Borini A, Bianchi L, Violini F, Maccolini A, Cattoli M, Flamigni C. Oocyte donation program: pregnancy and implantation rates in women of different ages sharing oocytes from single donor. Fertil Steril 1996; 65:94-97.
9. Bustillo M, Buster JE, Cohen SW, Thorneycroft IH, Simon JA, Boyers SP, Marshall JR, Seed RW, Louw JA, Seed RG. Nonsurgical ovum transfer as a treatment in infertile women. Preliminary experience. JAMA 1984; 251:1171-1173.
10. Chernyshov VP, Tumanova LE, Sudoma IA, Bannikov VI. Th1 and Th2 in human IVF pregnancy with allogenic fetus. Am J Reprod Immunol 2008; 59:352-358.
11. Claas FH, Roelen DL, van Rood JJ, Brand A. Modulation of the alloimmune response by blood transfusions. Transfus Clin Biol 2001;8:315-317.
12. Dankers MK, Witvliet MD, Roelen DL, de Lange P, Korfage N, Persijn GG, Duquesnoy R, Doxiadis II, Claas FH. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004;77:1236-1239.
13. Dekker GA, Robillard PY, Hulsey TC. Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998;53:377-382.
14. Dessolle L, Darai E, Cornet D, Rouzier R, Coutant C, Mandelbaum J, Antoine JM. Determinants of pregnancy rate in the donor oocyte model: a mutivariate analysis of 450 frozen-thawed embryo transfers. Hum Reprod 2009;24:3082-3089.
15. Dietl J, Honig A, Kammerer U, Rieger L. Natural killer cells and dendritic cells at the human feto-maternal interface: an effective cooperation? Placenta 2006;27:341-347.
16. Faber BM, Mercan R, Hamacher P, Muasher SJ, Toner JP. The impact of an egg donor's age and her prior fertility on recipient pregnancy outcome. Fertil Steril 1997;68:370-372.
17. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006;203:2165-2175.
18. Gorrill MJ, Johnson LK, Patton PE, Burry KA. Oocyte donor screening: the selection process and cost analysis. Fertil Steril 2001;75:400-404.
19. Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van SA, Devroey P, Ejdrup BH, Humaidan P. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril 2007;88:616-621.
20. Gundogan F, Bianchi DW, Scherjon SA, Roberts DJ. Placental pathology in egg donor pregnancies. Fertil Steril 2009;93:397-404.
21. Henne MB, Zhang M, Paroski S, Kelshikar B, Westphal LM. Comparison of obstetric outcomes in recipients of donor oocytes vs. women of advanced maternal age with autologous oocytes. J Reprod Med 2007; 52:585-590.
22. Hiby SE, Walker JJ, O'shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004;200:957-965.
23. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997;18:107-134.
24. Kavic SM, Sauer MV. Oocyte donation treats infertility in survivors of malignancies: ten-year experience. J Assist Reprod Genet 2001; 18:181-183.
25. Keegan DA, Krey LC, Chang HC, Noyes N. Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes. Fertil Steril 2007;87:776-781.
26. Kim HS, Yang KM, Cha SH, Song IO, Kang IS. Obstetric outcomes after oocyte donation in patients with premature ovarian failure. Abstracts of the 21st Annual Meeting of the ESHRE, Copenhagen, Denmark, 2005, p.O-094.
27. Klein J, Sauer MV. Oocyte donation. Best Pract Res Clin Obstet Gynaecol 2002;16:277-291.
28. Kramer W, Schneider J, Schultz N. US oocyte donors: a retrospective study of medical and psychosocial issues. Hum Reprod 2009; 24:3144-3149.
29. Krieg SA, Henne MB, Westphal LM. Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies. Fertil Steril 2008;90:65-70.
30. Lagaaij EL, Hennemann IP, Ruigrok M, de Haan MW, Persijn GG, Termijtelen A, Hendricks GF, Weimar W, Claas FH, van Rood JJ. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989;321:701-705.
31. Le Bouteiller P, Pizzato N, Barakonyi A, Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 2003;59:219-234.
32. Lipitz S, Admon D, Menczer J, Ben-Baruch G, Oelsner G. Midtrimester bleeding-variables which affect the outcome of pregnancy. Gynecol Obstet Invest 1991;32:24-27.
33. Lutjen P, Trounson A, Leeton J, Findlay J, Wood C, Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 1984;307:174-175.
34. Meniru GI, Craft IL. Experience with gestational surrogacy as a treatment for sterility resulting from hysterectomy. Hum Reprod 1997;12:51-54.
35. Michalas S, Loutradis D, Drakakis P, Milingos S, Papageorgiou J, Kallianidis K, Koumantakis E, Aravantinos D. Oocyte donation to women over 40 years of age: pregnancy complications. Eur J Obstet Gynecol Reprod Biol 1996;64:175-178.
36. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006;6:584-594.
37. Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, Grunfeld L. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet 1991;337:1375-1377.
38. Noyes N, Hampton BS, Berkeley A, Licciardi F, Grifo J, Krey L. Factors useful in predicting the success of oocyte donation: a 3-year retrospective analysis. Fertil Steril 2001;76:92-97.
39. Nyboe AA, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS, de Mouzon J, Nygren KG. Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 2009;24:1267-1287.
40. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253-259.
41. Pados G, Camus M, Van Steirteghem A, Bonduelle M, Devroey P. The evolution and outcome of pregnancies from oocyte donation. Hum Reprod 1994;9:538-542.
42. Paulson RJ, Hatch IE, Lobo RA, Sauer MV. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997;12:835-839.
43. Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman DE, Slater CC, Francis MM, Jain JK. Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA 2002; 288:2320-2323.
44. Perni SC, Predanic M, Cho JE, Baergen RN. Placental pathology and pregnancy outcomes in donor and non-donor oocyte in vitro fertilization pregnancies. J Perinat Med 2005;33:27-32.
45. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59:161-173.
46. Saito S, Tsukaguchi N, Hasegawa T, Michimata T, Tsuda H, Narita N. Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am J Reprod Immunol 1999; 42:240-245.
47. Saito S, Shiozaki A, Sasaki Y, Nakashima A, Shima T, Ito M. Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin Immunopathol 2007;29:115-122.
48. Salha O, Sharma V, Dada T, Nugent D, Rutherford AJ, Tomlinson AJ, Philips S, Allgar V, Walker JJ. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod 1999;14:2268-2273.
49. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy-an inflammatory view. Trends Immunol 2006;27:399-404.
50. Sauer MV. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. Am J Obstet Gynecol 2001; 184:277-278.
51. Sauer MV, Kavic SM. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online 2006; 12:153-162.
52. Sauer MV, Paulson RJ, Macaso TM, Francis MM, Lobo RA. Oocyte and pre-embryo donation to women with ovarian failure: an extended clinical trial. Fertil Steril 1991;55:39-43.
53. Sauer MV, Paulson RJ, Lobo RA. Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA 1992;268:1275-1279.
54. Sauer MV, Paulson RJ, Lobo RA. Oocyte donation to women of advanced reproductive age: pregnancy results and obstetrical outcomes in patients 45 years and older. Hum Reprod 1996;11:2540-2543.
55. Schneider J. Fatal colon cancer in a young egg donor: a physician mother's call for follow-up and research on the long-term risks of ovarian stimulation. Fertil Steril 2008;90:2016.e1-2016.e5.
56. Serhal PF, Craft IL. Oocyte donation in 61 patients. Lancet 1989; 1:1185-1187.
57. Shaw KJ, Sauer MV. Obstetric care of surrogates and recipients of donor oocytes. Semin Reprod Endocrinol 1995;13:237-243.
58. Sheffer-Mimouni G, Mashiach S, Dor J, Levran D, Seidman DS. Factors influencing the obstetric and perinatal outcome after oocyte donation. Hum Reprod 2002;17:2636-2640.
59. Shulman A, Frenkel Y, Dor J, Levran D, Shiff E, Maschiach S. The best donor. Hum Reprod 1999;14:2493-2496.
60. Simchen MJ, Yinon Y, Moran O, Schiff E, Sivan E. Pregnancy outcome after age 50. Obstet Gynecol 2006;108:1084-1088.
61. Sindram-Trujillo AP, Scherjon SA, van Hulst-van Miert PP, van Schip JJ, Kanhai HH, Roelen DL, Claas FH. Differential distribution of NK cells in decidua basalis compared with decidua parietalis after uncomplicated human term pregnancy. Hum Immunol 2003;64: 921-929.
62. Soares SR, Troncoso C, Bosch E, Serra V, Simon C, Remohi J, Pellicer A. Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. J Clin Endocrinol Metab 2005;90:4399-4404.
63. Soderstrom-Anttila V, Sajaniemi N, Tiitinen A, Hovatta O. Health and development of children born after oocyte donation compared with that of those born after in-vitro fertilization, and parents' attitudes regarding secrecy. Hum Reprod 1998a;13:2009-2015.
64. Soderstrom-Anttila V, Tiitinen A, Foudila T, Hovatta O. Obstetric and perinatal outcome after oocyte donation: comparison with in-vitro fertilization pregnancies. Hum Reprod 1998b;13:483-490.
65. Stolwijk AM, Zielhuis GA, Sauer MV, Hamilton CJ, Paulson RJ. The impact of the woman's age on the success of standard and donor in vitro fertilization. Fertil Steril 1997;67:702-710.
66. Styer AK, Parker HJ, Roberts DJ, Palmer-Toy D, Toth TL, Ecker JL. Placental villitis of unclear etiology during ovum donor in vitro fertilization pregnancy. Am J Obstet Gynecol 2003;189:1184-1186.
67. Sunderam S, Chang J, Flowers L, Kulkarni A, Sentelle G, Jeng G, Macaluso M. Assisted Reproductive Technology Surveillance-United States, 2006. MMWR 2009;58:1-25.
68. The Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in women. Fertil Steril 2004; 82(Suppl. 1):S90-S96.
69. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM, Kanhai HH, Claas FH, Scherjon SA. Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(2) T-cells in decidua and maternal blood during human pregnancy. Placenta 2006; 27(Suppl. A):S47-S53.
70. Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA, Claas FH. Evidence for a selective migration of fetus-specific CD4+/CD25bright regulatory T-cells from the peripheral blood to the human pregnancy. J Immunol 2008;180:5737-5745.
71. Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg V, Roelen DL, van Rood JJ, Claas FH. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol 2009a;82:148-157.
72. Tilburgs T, van der Mast BJ, Nagtzaam NM, Roelen DL, Scherjon SA, Claas FH. Expression of NK cell receptors on decidual T cells in human pregnancy. J Reprod Immunol 2009b;80:22-32.
73. Toner JP, Grainger DA, Frazier LM. Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience. Fertil Steril 2002;78:1038-1045.
74. van der Mast BJ, Balk AH. Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation. Transplantation 1997; 63:1514-1519.
75. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353-356.
76. Wen P. To tell truth. The Boston Globe, 4 February 2008.
77. Wiggins DA, Main E. Outcomes of pregnancies achieved by donor egg in vitro fertilization-a comparison with standard in vitro fertilization pregnancies. Am J Obstet Gynecol 2005;92:2002-2006.
78. Williams Z, Zepf D, Longtine J, Anchan R, Broadman B, Missmer SA, Hornstein MD. Foreign fetal cells persist in the maternal circulation. Fertil Steril 2009;91:2593-2595.
79. Yaron Y, Ochshorn Y, Amit A, Kogosowski A, Yovel I, Lessing JB. Oocyte donation in Israel: a study of 1001 initiated treatment cycles. Hum Reprod 1998;13:1819-1824.